In a press release issued today, Pfizer Inc announced the discontinuation of one of its Phase 3 studies using Sutent in advanced breast cancer.

In a press release issued today, Pfizer Inc announced the discontinuation of one of its Phase 3 studies using Sutent in advanced breast cancer.